Screener
Prime Medicine PRME Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands) | Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value |
|---|---|---|---|---|
| Short-term investments in debt securities: | ||||
| U.S. Treasury and government securities | $36,074 | — | $(4) | $36,070 |
| Corporate debt securities | 11,555 | — | (5) | 11,550 |
| Total short-term investments in debt securities | $47,629 | — | $(9) | $47,620 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's unrealized losses on investments (before tax)?
- Prime Medicine (PRME) reported unrealized losses on investments (before tax) of $9K in Q2 2026.
- How has Prime Medicine's unrealized losses on investments (before tax) changed year-over-year?
- Prime Medicine's unrealized losses on investments (before tax) decreased by 10.0% year-over-year, from $10K to $9K.
- What is the long-term trend for Prime Medicine's unrealized losses on investments (before tax)?
- Over 3 years (2022 to 2025), Prime Medicine's unrealized losses on investments (before tax) has grown at a -80.2% compound annual growth rate (CAGR), from $384K to $3K.
- What does unrealized losses on investments (before tax) mean?
- The total unrealized losses on investments, typically related to available-for-sale securities, before considering tax effects.
Ask your AI about Prime Medicine's unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude